PRKAA1 rs13361707 C/T polymorphism confers decreased susceptibility to esophageal cancer: A case‐control study

BACKGROUND: Several studies probed into the connection between esophageal cancer (EC) risk and PRKAA1 rs13361707 C/T polymorphism, but obtained insignificant findings. METHODS: In this study, 814 EC cases and 961 controls from Eastern China were recruited to validate the relationship between this po...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Cheng‐Lin, Zhao, Jian‐Qiang, Zang, Bao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521242/
https://www.ncbi.nlm.nih.gov/pubmed/32488984
http://dx.doi.org/10.1002/jcla.23406
Descripción
Sumario:BACKGROUND: Several studies probed into the connection between esophageal cancer (EC) risk and PRKAA1 rs13361707 C/T polymorphism, but obtained insignificant findings. METHODS: In this study, 814 EC cases and 961 controls from Eastern China were recruited to validate the relationship between this polymorphism and EC susceptibility. RESULTS: Data suggested rs13361707 C/T polymorphism in PRKAA1 gene was significantly related with a lower risk for EC. Such significant connection was also uncovered in subgroups of males, smokers, drinkers and individuals with age ≥ 60 years. In addition, this polymorphism was linked with the pathological grading, distant metastasis, and histology of EC. CONCLUSION: In summary, PRKAA1 rs13361707 C/T polymorphism is related to the risk and clinical properties of EC patients in East China.

Ejemplares similares